Biophysical constraints of influenza neuraminidase evolution

流感神经氨酸酶进化的生物物理限制

基本信息

项目摘要

PROJECT SUMMARY Seasonal influenza epidemic causes 3-5 million infections and 250,000 to 500,000 deaths every year. While seasonal influenza vaccine is available and being constantly updated, its effectiveness is often hampered by the rapid antigenic drift of circulating strains. As a result, a major goal of influenza research is to develop a more effective vaccine. Nevertheless, the poor ability to forecast the evolution of influenza virus poses a huge challenge in influenza vaccine development. Consequently, understanding how the evolutionary trajectories of influenza virus are being shaped can significantly benefit public health. Influenza virus has two surface antigens, namely hemagglutinin (HA) and neuraminidase (NA). While influenza vaccine development has traditionally focused on targeting the HA, NA has received increasing attention as an effective vaccine target in recent years. Evolution of NA is under several biophysical constraints including protein stability, surface expression, and enzymatic activity. These biophysical constraints determine not only the fitness effects of individual mutations, but also how these fitness effects vary in the presence of other mutations (i.e. epistasis). In fact, epistasis has been a main obstacle in evolution forecast since epistasis can lead to opposite fitness effects of the same mutation in different influenza strains. This proposed study will use innovative high- throughput experiments to systematically probe the fitness effects of all possible amino-acid mutations on NA and map epistatic interactions that are involved in the natural evolution of NA. In addition, the molecular mechanisms of epistasis will be characterized by biochemical and structural biology approaches. Statistical modeling will further be applied to quantify the relationships between biophysical constraints of NA and viral fitness. The results will comprehensively reveal the biophysical principles that govern the mutational fitness effects and epistatic interactions in influenza NA, and hence its evolutionary trajectories in natural evolution. This proposed study will therefore promote the construction of a unifying biophysical model to accurately forecast the evolution of influenza virus, which will in turn facilitate the development of next-generation influenza vaccines.
项目总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Nicholas C. Wu其他文献

Stringent and complex sequence constraints of an IGHV1-69 broadly neutralizing antibody to influenza Ha stem
针对流感 Ha 干细胞的 IGHV1-69 广泛中和抗体的严格且复杂的序列限制
  • DOI:
    10.1016/j.celrep.2023.113410
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    8.8
  • 作者:
    Qi Wen Teo;Yiquan Wang;Huibin Lv;Timothy J. C. Tan;R. Lei;Kevin J. Mao;Nicholas C. Wu
  • 通讯作者:
    Nicholas C. Wu
The in vivo ISGylome links ISG15 to metabolic pathways and autophagy upon Listeria monocytogenes infection
体内 ISGylome 将 ISG15 与李斯特菌感染后的代谢途径和自噬联系起来
  • DOI:
    10.1038/s41467-019-13393-x
  • 发表时间:
    2019-11-26
  • 期刊:
  • 影响因子:
    15.700
  • 作者:
    Yifeng Zhang;Fabien Thery;Nicholas C. Wu;Emma K. Luhmann;Olivier Dussurget;Mariko Foecke;Clara Bredow;Daniel Jiménez-Fernández;Kevin Leandro;Antje Beling;Klaus-Peter Knobeloch;Francis Impens;Pascale Cossart;Lilliana Radoshevich
  • 通讯作者:
    Lilliana Radoshevich
Crystal structure of C05 V110P/A117E mutant bound to H3 influenza hemagglutinin, HA1 subunit
与 H3 流感血凝素、HA1 亚基结合的 C05 V110P/A117E 突变体的晶体结构
  • DOI:
  • 发表时间:
    2019
  • 期刊:
  • 影响因子:
    0
  • 作者:
    A. M. Sevy;Nicholas C. Wu;Iuliia M. Gilchuk;Erica H Parrish;Sebastian Burger;Dina Yousif;Marcus B. M. Nagel;K. Schey;Ian A. Wilson;James E. Crowe;Jens Meiler
  • 通讯作者:
    Jens Meiler
A library-on-library screen reveals the breadth expansion landscape of a broadly neutralizing betacoronavirus antibody
文库上的文库筛选揭示了广泛中和β冠状病毒抗体的广度扩展前景
  • DOI:
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Marya Y. Ornelas;Wenhao O. Ouyang;Nicholas C. Wu
  • 通讯作者:
    Nicholas C. Wu
Targeting neuraminidase: the next frontier for broadly protective influenza vaccines
靶向神经氨酸酶:广泛保护性流感疫苗的下一个前沿领域
  • DOI:
    10.1016/j.it.2023.11.001
  • 发表时间:
    2024-01-01
  • 期刊:
  • 影响因子:
    13.900
  • 作者:
    Nicholas C. Wu;Ali H. Ellebedy
  • 通讯作者:
    Ali H. Ellebedy

Nicholas C. Wu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Nicholas C. Wu', 18)}}的其他基金

Biophysical constraints of influenza neuraminidase evolution
流感神经氨酸酶进化的生物物理限制
  • 批准号:
    10654846
  • 财政年份:
    2022
  • 资助金额:
    $ 51.23万
  • 项目类别:
Sequence-function relationship of influenza broadly neutralizing antibodies
流感广泛中和抗体的序列-功能关系
  • 批准号:
    10555301
  • 财政年份:
    2022
  • 资助金额:
    $ 51.23万
  • 项目类别:
Sequence-function relationship of influenza broadly neutralizing antibodies
流感广泛中和抗体的序列-功能关系
  • 批准号:
    10415666
  • 财政年份:
    2022
  • 资助金额:
    $ 51.23万
  • 项目类别:
Sequence-function relationship of influenza broadly neutralizing antibodies
流感广泛中和抗体的序列-功能关系
  • 批准号:
    10898173
  • 财政年份:
    2022
  • 资助金额:
    $ 51.23万
  • 项目类别:
High-throughput identification of antibody features for sequence-based epitope prediction
高通量鉴定抗体特征以进行基于序列的表位预测
  • 批准号:
    10243575
  • 财政年份:
    2021
  • 资助金额:
    $ 51.23万
  • 项目类别:
MECHANISTIC UNDERSTANDING OF INFLUENZA-HOST INTERACTIONS FROM A ZOONOTIC PERSPECTIVE
从人畜共患病的角度理解流感-宿主相互作用的机制
  • 批准号:
    10217310
  • 财政年份:
    2019
  • 资助金额:
    $ 51.23万
  • 项目类别:
MECHANISTIC UNDERSTANDING OF INFLUENZA-HOST INTERACTIONS FROM A ZOONOTIC PERSPECTIVE
从人畜共患病的角度理解流感-宿主相互作用的机制
  • 批准号:
    10242968
  • 财政年份:
    2019
  • 资助金额:
    $ 51.23万
  • 项目类别:

相似海外基金

Double Incorporation of Non-Canonical Amino Acids in an Animal and its Application for Precise and Independent Optical Control of Two Target Genes
动物体内非规范氨基酸的双重掺入及其在两个靶基因精确独立光学控制中的应用
  • 批准号:
    BB/Y006380/1
  • 财政年份:
    2024
  • 资助金额:
    $ 51.23万
  • 项目类别:
    Research Grant
Quantifying L-amino acids in Ryugu to constrain the source of L-amino acids in life on Earth
量化 Ryugu 中的 L-氨基酸以限制地球生命中 L-氨基酸的来源
  • 批准号:
    24K17112
  • 财政年份:
    2024
  • 资助金额:
    $ 51.23万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: RUI: Elucidating Design Rules for non-NRPS Incorporation of Amino Acids on Polyketide Scaffolds
合作研究:RUI:阐明聚酮化合物支架上非 NRPS 氨基酸掺入的设计规则
  • 批准号:
    2300890
  • 财政年份:
    2023
  • 资助金额:
    $ 51.23万
  • 项目类别:
    Continuing Grant
Basic research toward therapeutic strategies for stress-induced chronic pain with non-natural amino acids
非天然氨基酸治疗应激性慢性疼痛策略的基础研究
  • 批准号:
    23K06918
  • 财政年份:
    2023
  • 资助金额:
    $ 51.23万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular mechanisms how arrestins that modulate localization of glucose transporters are phosphorylated in response to amino acids
调节葡萄糖转运蛋白定位的抑制蛋白如何响应氨基酸而被磷酸化的分子机制
  • 批准号:
    23K05758
  • 财政年份:
    2023
  • 资助金额:
    $ 51.23万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular recognition and enantioselective reaction of amino acids
氨基酸的分子识别和对映选择性反应
  • 批准号:
    23K04668
  • 财政年份:
    2023
  • 资助金额:
    $ 51.23万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Design and Synthesis of Fluorescent Amino Acids: Novel Tools for Biological Imaging
荧光氨基酸的设计与合成:生物成像的新工具
  • 批准号:
    2888395
  • 财政年份:
    2023
  • 资助金额:
    $ 51.23万
  • 项目类别:
    Studentship
Structurally engineered N-acyl amino acids for the treatment of NASH
用于治疗 NASH 的结构工程 N-酰基氨基酸
  • 批准号:
    10761044
  • 财政年份:
    2023
  • 资助金额:
    $ 51.23万
  • 项目类别:
Lifestyle, branched-chain amino acids, and cardiovascular risk factors: a randomized trial
生活方式、支链氨基酸和心血管危险因素:一项随机试验
  • 批准号:
    10728925
  • 财政年份:
    2023
  • 资助金额:
    $ 51.23万
  • 项目类别:
Single-molecule protein sequencing by barcoding of N-terminal amino acids
通过 N 端氨基酸条形码进行单分子蛋白质测序
  • 批准号:
    10757309
  • 财政年份:
    2023
  • 资助金额:
    $ 51.23万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了